Health score, competitive moat, risk signals, and key metrics at a glance.
Competitive analysis based on 67 quarters of fundamental data
Operating margins are positive at ~20.6% on average, but show some variability — pricing power may be sensitive to market conditions.
ROE averages 15.2% but has fluctuated — the competitive advantage may be cyclical or emerging.
Data-driven red flags and warnings across 67 quarters
Operating margins dropped 34.4% over recent quarters — a sharp decline suggesting serious cost or pricing challenges.
FCF covers net income by 1.2x on average — earnings are well-supported by cash generation.
D/E ratio is 0.8 — conservative capital structure with low financial risk.
Revenue has softened, declining in 5 quarters. Monitor for further erosion.
Free cash flow is consistently positive — the business self-funds without external capital reliance.
Shares outstanding increased 90853.9% — significant dilution, likely from stock compensation or capital raises.
as of December 2025
Revenue, EBITDA, operating income, net income, EPS, and shares
Gross, EBITDA, operating, and net margin trends
P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield
Total assets, cash, debt, book value, and leverage
Operating cash flow, free cash flow, FCF margin, and earnings quality
8 of the last 8 quarters generated positive FCF. The company generally funds itself but has occasional cash consumption quarters.
Revenue has been flat or declining over recent quarters, which may indicate eroding demand or competitive pressure.
